Lipidic cubic-phase leflunomide nanoparticles (cubosomes) as a potential tool for breast cancer management

Despite the fact of availability of several treatments for breast cancer, most of them fail to attain the desired therapeutic response due to their poor bioavailability, high doses, non-selectivity and as a result systemic toxicity. Here in an attempt made to study the transdermal effect of leflunom...

Descripción completa

Detalles Bibliográficos
Autores principales: Zewail, Mariam, E. Gaafar, Passent M., Ali, Mai M., Abbas, Haidy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9154769/
https://www.ncbi.nlm.nih.gov/pubmed/35616281
http://dx.doi.org/10.1080/10717544.2022.2079770

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9154769/
https://www.ncbi.nlm.nih.gov/pubmed/35616281
http://dx.doi.org/10.1080/10717544.2022.2079770

Ejemplares similares